NEUTRISCI INTL WKN: A12GAQ ISIN: CA64129Y1079 Kürzel: NU Forum: Aktien Thema: Hauptdiskussion

Die Firma hat sich als bumsbude herausgestellt, was dieser Glenda treibt ist ein Witz. Man kann nur jedem von einem Invest abraten

Naja was erwartest du @new investor

Nur noch Schrott Beiträge hier

Schrott

Klar ist die Meldung alt, steht ja drüber. Bin nur erst heut drüber gestolpert.

Eher des Jahrtausends

Eher des Jahrtausends

Müll des Jahrhunderts….

aaallltttt..... die Meldung gabs schon vor ein paar Tagen.. 🙈

Pilze, es gibt Pilze

NeutriSci International Inc. Completes R&D of Effervescent Functional Mushroom Tablet 11/30/2021 | 07:09am EST NeutriSci International Inc. announced that is has successfully completed the R&D of a newly developed effervescent functional mushroom tablet product for online sales in Europe and North America. The new product line will consist of Reishi, Chaga, Cordyceps, Lion's Mane, Tremelle, and Turkey Tail mushrooms while containing a proprietary blend of CBD, CBN and or CBG; designed to complement the already potent health benefits of functional mushrooms. Packaging for the product is currently being finalized; designed around several flavor profiles, including citrus and berry. Functional mushrooms are packed with antioxidants and nutritional value. They are widely consumed due to their medicinal properties and superfood benefits. Furthermore, increasing acceptability of mushroom for medicinal properties is boosting the sales and profit of the players currently operating in the market, which in turn, is expected to further drive the market growth for functional mushrooms. Mushrooms that support immune health have benefited since the start of the COVID-19 pandemic, with high interest from food, beverage, and nutritional supplement manufacturers, which has carried over to the entire mushroom category. © S&P Capital IQ 2021

😄 bestimmt von der einen Palette neulich

😂🙈

https://twitter.com/neutrisci/status/1467901369650585601?t=dRBaiTfWOFNdPq0QYeCunQ&s=19 Erste Order aus Florida wird ausgeliefert.

zur Info...

NeutriSci International Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was CAD 0.330061 million compared to CAD 0.632687 million a year ago. For the nine months, sales was CAD 0.05502 million compared to CAD 0.067981 million a year ago. Net loss was CAD 1.21 million compared to CAD 1.4 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. Diluted loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. © S&P Capital IQ 2021